Literature DB >> 25569387

Long-term follow-up study of radial forearm free flap reconstruction after hemiglossectomy.

Masaya Akashi1, Kazunobu Hashikawa, Akiko Sakakibara, Takahide Komori, Hiroto Terashi.   

Abstract

Previous studies on postoperative long-term results in patients who underwent reconstructive free flap transfer following hemiglossectomy had some issues, including the heterogeneity of the patient population and the observation period. The present study aimed to evaluate changes of reconstructed tongues in patients who underwent radial forearm free flap (RFFF) after hemiglossectomy with long-term follow-up. We enrolled 23 patients who underwent RFFF after hemiglossectomy with a postoperative follow-up of 5 years or more. Postoperative status (eating, speech, sensation function) was assessed by concise medical inquiries. Morphological changes of flaps were evaluated by reviewing clinical photographs. Hemiglossectomy involving the base of the tongue was performed in 4 cases (17.4%) and was limited to the mobile tongue in 19 cases (82.6%). The mean follow-up was 85.4 months (range, 60-122 months). All patients experienced gradually improved postoperative status. The most significant improvement was found between 1 and 5 years after surgery (P = 0.007), but not between 1 and 3 years (P = 0.075) or between 3 and 5 years (P = 0.530). In almost all of the flaps, there were few morphological changes throughout the follow-up period. Postoperative status in patients who underwent reconstructive RFFF following hemiglossectomy improved sequentially.

Entities:  

Mesh:

Year:  2015        PMID: 25569387     DOI: 10.1097/SCS.0000000000001176

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  1 in total

1.  Assessing the suitability of medial sural artery perforator flaps in tongue reconstruction - An outcome study.

Authors:  Shao-Yu Hung; Charles Yuen Yung Loh; Soo-Ha Kwon; Chia-Hsuan Tsai; Kai-Ping Chang; Huang-Kai Kao
Journal:  PLoS One       Date:  2017-02-09       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.